123 related articles for article (PubMed ID: 8914860)
1. Effect of the non-peptide blocker (+/-) CP 96,345 on the cellular mechanism involved in the response to NK1 receptor stimulation in human skin fibroblasts.
Ziche M; Parenti A; Amerini S; Zawieja D; Maggi CA; Ledda F
Neuropeptides; 1996 Aug; 30(4):345-54. PubMed ID: 8914860
[TBL] [Abstract][Full Text] [Related]
2. The tachykinin NK1 receptor mediates the migration-promoting effect of substance P on human skin fibroblasts in culture.
Parenti A; Amerini S; Ledda F; Maggi CA; Ziche M
Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):475-81. PubMed ID: 8740139
[TBL] [Abstract][Full Text] [Related]
3. Receptors mediating tachykinin-evoked depolarisations of neurons in the neonatal rat spinal cord.
Fox AJ; Naeem S; Patel IA; Walpole C; Urbán L
Acta Biol Hung; 1996; 47(1-4):129-44. PubMed ID: 9123986
[TBL] [Abstract][Full Text] [Related]
4. Evidence that tachykinin NK1 and NK2 receptors mediate non-adrenergic non-cholinergic excitation and contraction in the circular muscle of guinea-pig duodenum.
Zagorodnyuk V; Santicioli P; Maggi CA; Giachetti A
Br J Pharmacol; 1995 May; 115(2):237-46. PubMed ID: 7545517
[TBL] [Abstract][Full Text] [Related]
5. Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea-pig ileum and proximal colon.
Maggi CA; Patacchini R; Meini S; Quartara L; Sisto A; Potier E; Giuliani S; Giachetti A
Br J Pharmacol; 1994 May; 112(1):150-60. PubMed ID: 7518302
[TBL] [Abstract][Full Text] [Related]
6. Evidence that tachykinins relax the guinea-pig trachea via nitric oxide release and by stimulation of a septide-insensitive NK1 receptor.
Figini M; Emanueli C; Bertrand C; Javdan P; Geppetti P
Br J Pharmacol; 1996 Mar; 117(6):1270-6. PubMed ID: 8882625
[TBL] [Abstract][Full Text] [Related]
7. Effect of the tachykinin NK1 receptor antagonists, RP 67580 and SR 140333, on electrically-evoked substance P release from rat spinal cord.
Malcangio M; Bowery NG
Br J Pharmacol; 1994 Oct; 113(2):635-41. PubMed ID: 7530576
[TBL] [Abstract][Full Text] [Related]
8. Tachykinin NK1 and NK2 receptors mediate non-adrenergic non-cholinergic excitatory neuromuscular transmission in the human ileum.
Zagorodnyuk V; Santicioli P; Turini D; Maggi CA
Neuropeptides; 1997 Jun; 31(3):265-71. PubMed ID: 9243524
[TBL] [Abstract][Full Text] [Related]
9. Demonstration of a 'septide-sensitive' inflammatory response in rat skin.
Ahluwalia A; Giuliani S; Maggi CA
Br J Pharmacol; 1995 Oct; 116(4):2170-4. PubMed ID: 8564245
[TBL] [Abstract][Full Text] [Related]
10. Specialization of tachykinin NK1 and NK2 receptors in producing fast and slow atropine-resistant neurotransmission to the circular muscle of the guinea-pig colon.
Maggi CA; Zagorodnyuk V; Giuliani S
Neuroscience; 1994 Dec; 63(4):1137-52. PubMed ID: 7535393
[TBL] [Abstract][Full Text] [Related]
11. Tachykinin NK1 receptor subtypes in the rat urinary bladder.
Meini S; Patacchini R; Maggi CA
Br J Pharmacol; 1994 Mar; 111(3):739-46. PubMed ID: 7517327
[TBL] [Abstract][Full Text] [Related]
12. Comparative, general pharmacology of SDZ NKT 343, a novel, selective NK1 receptor antagonist.
Walpole CS; Brown MC; James IF; Campbell EA; McIntyre P; Docherty R; Ko S; Hedley L; Ewan S; Buchheit KH; Urban LA
Br J Pharmacol; 1998 May; 124(1):83-92. PubMed ID: 9630347
[TBL] [Abstract][Full Text] [Related]
13. Gastric chief cells possess NK1 receptors which mediate pepsinogen secretion and are regulated by agents that increase cAMP and phospholipase C.
Kitsukawa Y; Turner RJ; Pradhan TK; Jensen RT
Biochim Biophys Acta; 1996 Jun; 1312(2):105-16. PubMed ID: 8672532
[TBL] [Abstract][Full Text] [Related]
14. Characterization of receptors mediating contraction induced by tachykinins in the guinea-pig isolated common bile duct.
Patacchini R; Barthó L; Maggi CA
Br J Pharmacol; 1997 Dec; 122(8):1633-8. PubMed ID: 9422808
[TBL] [Abstract][Full Text] [Related]
15. Higher potency of RP 67580, in the mouse and the rat compared with other nonpeptide and peptide tachykinin NK1 antagonists.
Beaujouan JC; Heuillet E; Petitet F; Saffroy M; Torrens Y; Glowinski J
Br J Pharmacol; 1993 Mar; 108(3):793-800. PubMed ID: 7682138
[TBL] [Abstract][Full Text] [Related]
16. The interaction of the NK1 receptor antagonist CP-96,345 with L-type calcium channels and its functional consequences.
Guard S; Boyle SJ; Tang KW; Watling KJ; McKnight AT; Woodruff GN
Br J Pharmacol; 1993 Sep; 110(1):385-91. PubMed ID: 7693284
[TBL] [Abstract][Full Text] [Related]
17. Tachykinin NK1 and NK2 receptors mediate non-adrenergic non-cholinergic excitatory neuromuscular transmission in the guinea-pig stomach.
Zagorodnyuk V; Maggi CA
Neuroscience; 1997 Sep; 80(2):625-34. PubMed ID: 9284363
[TBL] [Abstract][Full Text] [Related]
18. The effects of neurokinin-1 receptor agonists on spinal motoneurones of the neonatal rat.
Lepre M; Olpe HR; Brugger F
Neuropharmacology; 1996 Apr; 35(4):511-22. PubMed ID: 8793915
[TBL] [Abstract][Full Text] [Related]
19. Tachykinin NK1 receptor in the guinea-pig isolated proximal urethra: characterization by receptor selective agonists and antagonists.
Maggi CA; Patacchini R
Br J Pharmacol; 1992 Aug; 106(4):888-92. PubMed ID: 1327390
[TBL] [Abstract][Full Text] [Related]
20. Intracellular signaling pathway of substance P-induced superoxide production in human neutrophils.
Tanabe T; Otani H; Bao L; Mikami Y; Yasukura T; Ninomiya T; Ogawa R; Inagaki C
Eur J Pharmacol; 1996 Mar; 299(1-3):187-95. PubMed ID: 8901022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
